Tofacitinib alleviated salivary gland inflammation and reduced the percentages of effector T cells in murine Sjogren's disease. Liu Q, Xing X, He J. Clin Exp Rheumatol 2024;42:2437-2443.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu Q, Xing X, He J. Tofacitinib alleviated salivary gland inflammation and reduced the percentages of effector T cells in murine Sjogren's disease. Clin Exp Rheumatol 2024;42:2437-2443.
PMID: 39480504